Carlo Cattrini

Sex Hormones and Hormone Therapy during COVID-19 Pandemic: Implications for Patients with Cancer

Carlo Cattrini, Melissa Bersanelli, Maria Maddalena Latocca et al. · Cancers · 2020 · 73 citations · Full text

Hormonal Contraceptive, Sex Hormones, Tmprss2 Inhibitors +16

Treatment patterns and outcomes in metastatic castration-resistant prostate cancer patients with and without somatic or germline alterations in homologous recombination repair genes

David Olmos, David Lorente, Daniel Alameda et al. · Annals of Oncology · 2024 · 63 citations · Full text

Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

Matteo Santoni, Sebastiano Buti, Zin Myint et al. · European Urology Oncology · 2023 · 52 citations · Full text

Differential Effectiveness, Urology, Genitourinary Cancer +7

Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients

Carlo Cattrini, A. Rubagotti, Linda Zinoli et al. · Cancers · 2019 · 34 citations · Full text

Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study

Matteo Santoni, Francesco Massari, Zin Myint et al. · Targeted Oncology · 2023 · 34 citations · Full text

Immuno-oncology Combinations, Urology, Kidney Transplant +7